MARTHA BERRY: Open Payments
NPI 1073569828 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$292 in 15 payments from 10 companies in 2025. Trend: 2023 $300 · 2024 $306 · 2025 $292
Food & beverage: $292
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $57 |
| Novo Nordisk Inc | 2 | $40 |
| Astellas Pharma US Inc | 2 | $38 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: Veozah, GARDASIL 9, QULIPTA, LINZESS, Rybelsus, LEQVIO, AIRSUPRA, MOUNJARO.
Industry payments across AR — which companies pay providers there.
